W Zhang

1.3k citations
19 papers · 1.0k indexed · h-index 13

W Zhang

18 papers receiving 1.0k citations

Peers

W Zhang
Comparison fields: 5 of 75
  • Cancer Research 259
  • Oncology 437
  • Hematology 144
  • Immunology 225
  • Genetics 90
Replace Fumihiko Matsuno with:
Fumihiko Matsuno Japan
Robert Tressler United States
Maya Zigler United States
Lorraine Tracey Spain
Natalia Marchenko United States
John Nip United States
Erika Zonari Italy
Miriam Marqués Spain
Thibault Voeltzel France
Kanji Hojo Japan
W Zhang relative to Fumihiko Matsuno Japan Fumihiko Matsuno's profile →
Citations per field
00.5×6.8×
Fumihiko Matsuno · 1×
Citations per year

Countries citing papers authored by W Zhang

Since Specialization
Citations

This map shows the geographic impact of W Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Zhang more than expected).

Fields of papers citing papers by W Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Zhang. The network helps show where W Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W Zhang Line = papers co-authored together W Zhang links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20240
2 20232
3 202317
4
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
20171
5 201678
6 2015360
7 201483
8 201349
9 201031
10 2008121
11 200528
12 200026
13 199928
14 19972
15 19972
16
High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.
199586
17 199460
18 19943
19
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.
199236

About W Zhang

W Zhang is a scholar working on Oncology, Hematology and Biotechnology, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), RNA Interference and Gene Delivery (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (259 citations), Oncology (437 citations) and Hematology (144 citations). W Zhang has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Jinyun Liu, Fangyu Guo, Y Wang, Samuel C. Mok, Fengxia Xue, Marina Konopleva, Teresa McQueen, Michael Andreeff, A. B. Deisseroth and David F. Claxton. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026